An adenomatous polyp, also known as an adenoma, is an abnormal growth of cells that forms on the colon's lining. These polyps are common, comprising around 70% of all colon polyps. Roughly one ...
The Fast Track designation is supported by data from a phase 2 trial that evaluated eRapa in 30 adult patients with FAP.
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a ...
with current standard care being surgical removal of the colon and rectum. The Phase 2 study of eRapa showed promising results, including a median 17% reduction in polyp burden and a 75% non ...
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis ... is characterized as a proliferation of polyps in the colon and/or rectum, usually occurring in ...
Underscores unmet need for a therapeutic alternative with the potential to delay or prevent surgical removal of the colon and/or rectum ... the treatment of familial adenomatous polyposis (FAP).